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Abstract
Cervical cancer is the second most common cancer in women worldwide and is mainly
caused by the human papillomavirus (HPV). The purpose of this study was to determine
whether there was a statistically significant difference in the diagnosis of cervical cancer
in women who received the HPV vaccine compared to women who did not receive the
vaccine, while considering demographic factors (race, ethnicity, level of education,
household income), personal risk factors (sexual orientation, cigarette use, diet, and type
of contraception use), and factors affecting access to healthcare (type of healthcare
coverage, delay in receiving medical care). This research study, guided by the social
cognitive theory, consisted of secondary data analysis from the 2017 Behavioral Risk
Factor Surveillance System for the females ages 18 to 60 who were diagnosed with
cervical cancer as well as those who tested negative for cervical cancer. Females may or
may not have received the HPV vaccine. Data were analyzed using binomial logistic
regression analysis. Ethnicity was a significant predictor of cervical cancer diagnosis, B =
-1.93, OR = 0.15, p < .001, indicating that Hispanic individuals were 0.15 times as likely
to have a diagnosis of cervical cancer. Based on the findings of this study, health care
organizations may wish to raise awareness of cervical cancer among certain ethnic or
racial groups. Furthermore, there could be a more proactive approach to cervical cancer
prevention and detection. The potential positive social change that could result from this
study is increased rate and timely administration of HPV vaccination for women, which
may lead to lower death rates from cervical cancer.
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Chapter 1: Introduction to the Study
Cervical cancer is the second most common cancer in women worldwide and is
mainly caused by the human papillomavirus (HPV; Fisher & Brundage, 2009; Hughes,
2009). Cervical cancer accounted for 9% (529,800) of the total new cancer cases
worldwide and 8% (275,100) of the total cancer deaths among females in 2008 (Jemal et
al., 2011). In the year 2017, 12,820 women in the United States were diagnosed with
cervical cancer, and there were 4,210 deaths (American Society of Clinical Oncology
[ASCO], 2018). Further, more than 85% of cervical cancer cases and deaths occur in
developing countries. India, the second most populous county in the world, accounts for
27% (77,100) of the total cervical cancer deaths (ASCO, 2018). Preventive measures are
needed and therefore the HPV vaccine is recommended for females between 13 and 60
years of age (Lindau et al., 2001).
In the state of Alabama, the incidence of and death rate for cervical cancer is
among the highest in the United States (Miller, 2016). However, HPV vaccination in
Alabama is currently not widely implemented in the state (Miller, 2016). It is important
to determine a more accurate period when HPV vaccine should be administered
particularly among teenage females. Literature about HPV vaccination and cervical
cancer is abundant, but little research has been found about personal risk factors, factors
affecting access to health care, and HPV vaccination in women based on demographic
factors. The potential positive social change that could result from this study is increased
rate and timely administration of HPV vaccination for women, which may lead to lower
death rates (Centers for Disease Control and Prevention [CDC], 2017). In this chapter, I
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will present information about the background for this study, purpose of this study,
research questions, theoretical framework, nature of study, assumptions, limitations, and
significance of this study.

Background
Cervical cancer is a type of cancer that affects a woman’s cervix, the lower
portion of the uterus that connects it to the vagina (“Cervical Cancer,” n.d.). Cervical
cancer starts in the cells lining the cervix—the lower part of the uterus (womb; American
Cancer Society, 2018). These cancer cells grow uncontrollably, forming a tumor that may
spread to tissues around the cervix and may even break off and end up in other parts of
the body (Garvit, 2012). But HPV vaccine and its timely administration plays a
significant role in controlling the incidence of cervical cancer (Petry, 2014). HPV is one
of the most common sexually transmitted infections (Williams et al., 2015). However,
despite the availability of vaccines to prevent HPV, the U.S. vaccination rate falls below
the 80% national objective.
Furthermore, previous research has reported the associations between HPV
vaccine acceptability and parental characteristics, including sociodemographic factors,
knowledge, perceived vaccine effectiveness, risk perceptions, and vaccine cost (Williams
et al., 2015). Family history is beyond control when assessing the risks for cancer, but if
the mother or sister of a patient has had cervical cancer, the likelihood of developing
cancer increases by two to three times (American Cancer Society, 2018). Women who
have a weak immune system due to HIV or taking immunosuppressive drugs can have a
weaker immune system to fight off early cancer (Blake et al., 2015). Research shows that
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patients who have chlamydia infection are at an increased risk for developing cancer of
the cervix as well (Hirth et al., 2015). Therefore, the HPV vaccine is recommended for
females between 13 and 60 years of age (Arbyn et al., 2015).
This study addressed possible demographic and personal risk factors for cervical
cancer leading to higher death rates in certain racial groups of females (Tabatbhai et al.,
2014). For example, in the state of Alabama, the death rate due to cervical cancer is
higher in Black women as compared to White women (Miller, 2016). Research reveals
that the incidence rate of cervical cancer is 10.1 in White females and 7.6 in Black
females, whereas death rate due to cervical cancer is 3.4 in White females and 5.4 in
Black females (rates are per 100,000 persons and are age-adjusted to the 2000 U.S.
standard population)(CDC, 2017). This indicates that out of the women who are
diagnosed with cervical cancer, approximately 71% of Black women succumb to cervical
cancer, whereas for White women, it is only around 33%.

Problem Statement
Cervical cancer is the third most diagnosed cancer and the fourth leading cause of
cancer death in females worldwide (Miller, 2016), which has disproportionately affected
certain racial groups (CDC, 2017). In 2017, 12,820 women in the United States were
diagnosed with cervical cancer, and 4,210 died from the disease (ASCO, 2018). The rate
of the diagnosis of cervical cancer in Alabama is much lower than the national survey’s
results, which could be attributed to several system barriers such as perceived lack of
patient interest, insufficient reimbursement, and perceived parental hesitancy (Hastings et
al., 2017).
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In the past 40 years, the cases of cervical cancer and death rates have substantially
subsided because of an increased number of women obtaining pap tests more frequently,
which reveals cervical precancerous before it has extended its stage of cancer (CDC,
2017). But research has suggested that the HPV vaccine provision in community
pharmacies is low. Of pharmacies providing vaccinations, only 11.7% had the HPV
vaccine in their inventory (Hastings et al., 2017). As 68.1% of pharmacists reported that
they do not plan to offer or continue offering the vaccine in the next year. Thus, future
research should demonstrate successful HPV vaccine services in community pharmacies
and outline strategies to overcome system barriers and parental hesitancy (Hastings et al.,
2017). The study was conducted to address possible risk factors in reference to cervical
cancer vaccination programs.

Purpose of the Study
The purpose of this study was to determine whether there was a statistically
significant difference in the diagnosis of cervical cancer in women who received the HPV
vaccine compared to women who did not receive the vaccine, considering demographic
factors (race, ethnicity, level of education, household income), personal risk factors
(sexual orientation, cigarette use, diet, and type of contraception use), and factors
affecting access to healthcare (type of healthcare coverage, delay in receiving medical
care). An additional purpose of this study was to determine whether there was a
significant difference in the diagnosis of cervical cancer in women who received the HPV
vaccine based on the number of HPV shots received and the presence sexual activity.
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Research Questions and Hypotheses
Research Question 1: Is there a statistically significant difference in the diagnosis
of cervical cancer in women who received and did not receive the HPV vaccine
considering demographic factors (race, ethnicity, level of education, household income)
and factors affecting access to healthcare (type of healthcare coverage, delay in receiving
medical care)?

H01: There is no statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering
demographic factors (race, ethnicity, level of education, household income) and factors
affecting access to healthcare (type of healthcare coverage, delay in receiving medical
care).

H11: There is a statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering
demographic factors (race, ethnicity, level of education, household income) and factors
affecting access to healthcare (type of healthcare coverage, delay in receiving medical
care).
Research Question 2: Is there statistically significant difference in the diagnosis of
cervical cancer in women who received and did not receive the HPV vaccine considering
personal risk factors (sexual orientation, cigarette use, diet, and type of contraception
use)?
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H02: There is no statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering personal
risk factors (sexual orientation, cigarette use, diet, and type of contraception use).

H12: There is a statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering personal
risk factors (sexual orientation, cigarette use, diet, and type of contraception use).
Research Question 3: Is there a statistically significant difference in the diagnosis
of cervical cancer in women who received the HPV vaccine based on the number of HPV
shots received, and the presence of sexual activity?

H03: There is no statistically significant difference in the diagnosis of cervical
cancer in women who received the HPV vaccine based on the number of HPV shots
received, and the presence of sexual activity.

H13: There is a statistically significant difference in the diagnosis of cervical
cancer in women who received the HPV vaccine based on race, the number of HPV shots
received, and the presence of sexual activity.

Theoretical Framework
The theory that guided the study was social cognitive theory. Social cognitive
theory provides a framework for understanding, predicting, and changing human
behavior (Ryan, 2012). The theory identifies human behavior as an interaction of
personal factors, behavior, and the environment (Bandura, 1989). Social cognitive theory
was helpful for understanding and predicting both individual and group behavior and
identifying methods in which behavior can be modified or changed. The theory helped
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explain the pattern of change in human behavior regarding administration of HPV
vaccine during adolescence. The constructs used to measure the theory are divided into
dependent and independent constructs. The dependent constructs are learning and change
in behavior that would be measured in terms of incidence of cervical cancer; independent
constructs are personal factors (initiation of sexual activity, ethnicity, and lifestyle),
behavior (socioeconomic status), and environment (geographic location). The dependent
constructs of the theory depend on and respond to independent constructs of the theory.
This theory was chosen to provide an explanation incidence of cervical cancer as an
interaction of personal factors (initiation of sexual activity), behavior (lifestyle), and
environment (socioeconomic status; Bandura, 1989). A more detailed discussion of social
cognitive theory will be provided in Chapter 2.

Nature of Study
This research study used a quantitative research methodology, which was the
most appropriate because it emphasizes objective measurements and numerical/statistical
data for accurate explanation of a phenomenon. This study consisted of secondary data
analysis from the 2017 Behavioral Risk Factor Surveillance System (BRFSS). Selected
data from females between the ages of 18 to 60 who had been diagnosed with cervical
cancer as well as females who tested negative for cervical cancer was reviewed. The
independent variables were race, ethnicity, level of education, household income, type of
healthcare coverage, delay in receiving medical care, sexual orientation, cigarette use,
diet, type of contraception use, number of HPV shots received, and the presence of sexual
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activity. The dependent variable of the study was the diagnosis of cervical cancer. The
data collected were analyzed using binomial logistic regression analyses.

Definitions
Human papillomavirus (HPV): HPV is a viral infection that is passed between
people through skin-to-skin contact. Each HPV virus in this large group is given a
number that is called its HPV type (CDC, 2016). There are more than 100 varieties of
HPV, 40 of which are passed through sexual contact and can affect the genitals, mouth,
or throat (NCI Dictionary, n.d.).

Sexually active: Sexual activity in this study refers to sexual touching, oral sex,
anal sex, or vaginal sex (signalhealth, n.d.).

Socioeconomic status: Socioeconomic status is a theoretical construct
encompassing individual, household, and/or community access to resources. It is
commonly conceptualized as a combination of economic, social, and work status,
measured by income or wealth, education, and occupation, respectively (Psaki et al.,
2014).

Assumptions
The assumptions of this research study were that participants were truthful in the
information that they provided for dataset and that the variables that were used in this
study were available in the dataset. It was also assumed that the sample represents the
population and that the variables were measurable. It was also assumed that inclusion and
exclusion criteria of the study are appropriate (Hartas, 2010). Another assumption was
that the diagnosis of cervical cancer had been confirmed by a licensed physician. Finally,
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the assumption was that information collected from the dataset is accurate; however,
there is the possibility that a piece of information was not correctly recorded due to
human error.

Scope and Delimitations
This study was limited to women between 18 to 60 years of age and only to
females to make the study feasible, because I focused on the disparity between women of
different races regarding the diagnosis and mortality rate of cervical cancer. The threats
to validity included internal validity threats, external validity threats, construct validity
threats, and statistical conclusion validity threats. A threat to internal validity could arise
from the previous experiences of the participants that could influence the results. A threat
to external validity could be that the results of the study may not be generalizable to a
larger population of women in the United States, as the information is limited to a smaller
sample size. Statistical conclusion validity threats might arise if the conclusion of the
research study is influenced by the Type-I error rates during data collection.
The theories that were considered but not used included the self-efficacy theory
and the health belief model. The self-efficacy theory is based on the belief that some
people have the capability to produce the effect (Bandura, 1977). That is, it addresses the
power and ability to perform the courses of actions needed to manage situations. This
theory was not used because it was impossible to exclude outcome considerations from
efficacy expectations. The health belief model is based on following core beliefs based on
perceptions, which include perceived susceptibility, perceived severity, perceived
barriers, perceived benefits, perceived efficacy, perceived control, and perceived threat.
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The theory also considers variables like demographic variables and predicts the
probability of the studied individual to continue with the recommended health actions
which may be preventive or curative by nature (Glanz et al., 2002). However, this model
was not used as it does not account for a person’s attitudes, beliefs, or other individual
determinants that dictate a person’s acceptance of a health behavior.

Limitations
The major limitation of the study was that the data collected through a
questionnaire may have been biased and the participants may not have answered
accurately. As I used secondary data for my analysis, I was not able to address these
limitations. Another major limitation is the progress in the HPV vaccine over the period
when it was administered to the selected sample and the time of the research study. The
gap between the time of the collected data and the timing of the research study has
witnessed technological changes that might impact the validity of the research. In order to
address this limitation, I used the most recent available data relevant to my study.

Significance
The results of this quantitative study uniquely addressed the necessity for
administration of HPV vaccine in the women regardless of their age, ethnicity, and
economic status. The study results may enlighten individuals, the community, and society
about cervical cancer prevention from the perspective of women who suffered from the
disease. The potential positive social change that could result from this study is increased
rate and timely administration of HPV vaccination for women to decrease the incidence
of cervical cancer of women and lower the death rate due to cervical cancer. This
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research could also promote positive social change and advance knowledge by raising
awareness about the significance of HPV and the advantages of HPV vaccine in
preventing cervical cancer in women. The study may encourage routine administration of
HPV vaccine during adolescence as a professional practice in the United States to prevent
cervical cancer.

Summary
This quantitative study consisted of secondary data analysis from the 2017
BRFSS for females 18 to 60 years of age to determine whether a statistically significant
relationship existed between demographic and personal risk factors, HPV vaccination,
and cervical cancer throughout the United States. In Chapter 2, I provide my literature
search strategy, theoretical framework, and provide an overview of the current literature
on my research topic.
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Chapter 2: Literature Review
The prevalence and rise in the new cases of cervical cancer is witnessed in the
developing areas (Petry, 2014), and the rate of cervical cancer has increased worldwide
despite vaccine availability (Guglielmo et al., 2014). The purpose of this study was to
determine whether there was a statistically significant difference in the diagnosis of
cervical cancer between women who did and did not receive the HPV vaccine based on
demographic factors (race, ethnicity, level of education, household income), personal risk
factors (sexual orientation, cigarette use, diet, and type of contraception use), and factors
affecting access to healthcare (type of healthcare coverage, delay in receiving medical
care). I also examined whether there was a significant difference in the diagnosis of
cervical cancer in women who received the HPV vaccine based on the number of HPV
shots received and the presence or absence of sexual activity.
Chapter 2 will present information about the literature search strategy, the
theoretical framework, and a review of the literature related to cervical cancer, the HPV
vaccine, the incidence rate and death rate among women due to cervical cancer, the
factors associated with cervical cancer, and the preventive measures required to control
morbidity and mortality rates of cervical cancer as well as previous similar studies and
methodology used.

Literature Search Strategy
Literature was searched using Google along with the Walden Library Health
Sciences Research databases. Information was retrieved by searching through PubMed,
ProQuest, Google Scholar, Science Direct, and included peer reviewed journals,
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encyclopedias, scholarly articles, and books. The search terms that were used included

cervical cancer and HPV, HPV vaccine, cervical cancer incidence in Alabama, death
rate in Alabama, HPV vaccine benefits and effectiveness, cervical cancer in teenage
girls, resistance towards HPV vaccine, socioeconomic status and cervical cancer,
cervical cancer and ethnicity, social cognitive theory, quantitative research methodology,
binomial logistic regression, G-Power, and sample size.
The literature was searched from the year 2009 to current year. Every keyword
searched resulted in 150 to 200 results. All articles were peer reviewed. However, not all
the articles retrieved by the search were full text. For some of the articles, only the
abstract was available, but only full-text articles were used for the literature review. The
numbers for full-text articles after narrowing the inquiry reduced considerably. The
numbers of results also declined considerably when researched using Google Scholar.
The reference list of the articles and research studies selected provided additional
articles and resources. Several sources and the information from the Health Information
National Trends Survey was also relied on and included as per the relevance to my topic.
Some sources that provided significant information from older publications were also
included. Several journals exclusively for women’s health and related to cancer were
included as they provided unique and significant information. The magazines and opinion
surveys available through Google were also considered for obtaining more relevant
information and to keep searching for more reliable information.
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Theoretical Foundation
The social cognitive theory served as the theoretical framework for this research.
The theory originated from Albert Bandura (Bandura, 1989). The unique feature of the
social cognitive theory is the emphasis on social influence and its emphasis on external
and internal social reinforcement (Bandura, 1989). This theory takes into consideration
the unique way in which individuals acquire and maintain behavior while also
considering the social environment in which individuals perform the behavior (LaMorte,
2016). The theory also considers a person’s past experiences which factor into whether
behavioral action will occur (Ryan, 2012). These past experiences influence
reinforcements, expectations, and expectancies, all which shape whether a person will
engage in a specific behavior and the reasons why a person engages in that behavior
(LaMorte, 2016). For example, social cognitive theory can help explain how people adapt
healthier habits and reduce unhealthy habits (Bandura, 2004, p. 146).
The purpose of social cognitive theory is to explain how people regulate their
behavior through control and reinforcement to achieve goal-directed behavior that can be
maintained over time (LaMorte, 2016). The theory identifies human behavior as an
interaction of personal factors, behavior, and the environment (Bandura, 1989). The six
constructs of the social cognitive theory are reciprocal determinism, behavioral
capability, observational learning, reinforcements, expectations, and self-efficacy
(Bandura, 1989). Reciprocal determinism refers to the dynamic and reciprocal interaction
of person (individual with a set of learned experiences), environment (external social
context), and behavior (responses to stimuli to achieve goals) (Bandura, 1989). Thus, all
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three factors—environment, behavior, and personal factors—interact and influence each
other. This construct relates to my study as the change in behavior (i.e., the dependent
variable incidence of cervical cancer) could be observed based on the environment (i.e.,
the independent variable administration of HPV vaccine) as well as personal factors (i.e.,
the covariates of race, ethnicity, socioeconomic status).
Behavioral capability refers to a person’s actual ability to perform a behavior
through essential knowledge and skills (Bandura, 1989). This construct requires
providing adequate knowledge and skills for desirable behavioral changes. This construct
relates to my study as knowledge and skill (i.e., awareness and accessibility of HPV
vaccine) would result in change of behavior (i.e., more people opting for HPV
vaccination).
Observational learning asserts that people can witness and observe a behavior
conducted by others and then reproduce those actions (Bandura, 1989). For example,
witnessing the benefits of HPV vaccination can lead to more receiving the vaccine.
Similarly, reinforcements refer to the internal or external responses to a person’s behavior
that affect the likelihood of continuing or discontinuing the behavior (Bandura, 1989).
This construct is applicable to the people in helping them continue with the behavior
(dosages of HPV vaccination) based on their internal and external responses.
Expectations refer to the anticipated consequences of a person’s behavior.
Outcome expectations can be health-related or not health-related. People anticipate the
consequences of their actions before engaging in the behavior, and these anticipated
consequences can influence successful completion of the behavior (Bandura. 1989). Here
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expectation refers to the successful prevention from cervical cancer before engaging in
the behavior (administration of HPV vaccine).
Finally, self-efficacy refers to the level of a person’s confidence in his or her
ability to successfully perform a behavior (Bandura, 1989). This construct refers to the
mental strength of the individuals before they engage in a behavior (e.g., HPV
vaccination). Social cognitive theory is helpful for understanding and predicting both
individual and group behavior and identifying methods in which behavior can be
modified or changed. This theory can help in understanding the pattern of change in
human behavior regarding administration of HPV vaccine during adolescence. This
theory is the most appropriate for my research study because it helped identify the
incidence of cervical cancer as an interaction of personal factors (initiation of sexual
activity), behavior (lifestyle), and environment (geographic location, socioeconomic
status).
In previous research, social cognitive theory has been used to explain health
behavior like exercise as well as self-management of chronic disease. Allen (2004)
examined the literature on diabetes research using social cognitive theory to determine its
predictive ability in explaining exercise behavior and to identify key interventions that
enhance exercise initiation and maintenance. In correlational studies, a significant
relationship was found between self-efficacy and exercise behavior. The predictive
ability of outcome expectancies for exercise behavior demonstrated mixed results.
However, self-efficacy was predictive of exercise initiation and maintenance over a
period.
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Additionally, Sell et al. (2006) reviewed literature and demonstrated several gaps
in the literature regarding use of social support in self-management, impact of moral
disengagement, and studies specifically targeting older adults. The integrative review
explicated two areas related to the theory in need of further research. First, social support
has not been thoroughly explored as a mechanism for enhancing self-management
interventions. Second, moral disengagement was not identified as a focus within chronic
disease research raising the question about the impact of moral disengagement on longterm adherence and behavior change.

Literature Review Related to Key Concepts
Cervical Cancer Overview
Cervical cancer is a type of cancer that affects a woman’s cervix, which is mainly
caused by HPV, a sexually transmitted disease transferred through intercourse with
someone that has been previously affected (“Cervical Cancer,” n.d.). Because it is
acquired through sex, it is mostly contracted around the time of sexual maturity when a
female’s immune system defenses are at their lowest. When infected, a woman’s immune
system in some cases can fight off the disease and stop it before it develops into cervical
cancer (Gravitt, 2012). But in 60% of cases, a woman cannot fight off the disease and
cervical cancer precursor lesions are formed (Gravitt, 2012). These lesions cause some of
the affected epithelial cells on the woman’s uterus to transform into cancer cells and then
a tumor, which may spread to tissues around the cervix and may even break off and end
up in other parts of the body (“Cervical Cancer,” n.d.).
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Early cervical cancer has no manifestation in women and can go unnoticed until it
is too late. But when the disease progresses far enough, there are a few signs that women
should be aware of to recognize cervical cancer (Gravitt, 2012). One of the signs is blood
or discharge from the vagina during or after sex, between menstrual cycles, or after
menopause. This discharge may be thick, watery, and have a distinguishable foul odor.
Another sign is experiencing pain in the pelvic region during intercourse (“Cervical
Cancer,” n.d.). These signs should be noted and followed up by a health care
professional.
The controllable risk factors associated with cervical cancer also need to be made
clear to patients to decrease the odds of getting the disease. Smoking can cause a person
to be two times more likely of getting cervical cancer (Gravitt, 2012). The chemicals that
come from smoking are carried throughout the bloodstream and can be found in the
cervical mucus of those who smoke, and smoking causes the immune system to become
less effective in fighting off HPV. A diet with low amounts of fruits and vegetables and
being overweight can also increase the probability of developing cancer of the cervix
(Gravitt, 2012).
Family history is out of the control of anyone looking at the risks for cancer, but if
the mother or sister of a patient has had cervical cancer, the likelihood of developing
cancer increases by two to three times (American Cancer Society, 2018). The daughters
of a mother who took diethylstilbestrol during pregnancy to prevent a miscarriage are at
an increased risk for cancer of the cervix. Another medication that can increase the risk
includes birth control pills. The long-term use of birth control pills places a patient at an
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increased risk during use, but when the medication is stopped, the risk goes back to
before the use began.
Other factors that increase risk of cervical cancer are related to pregnancy, having
a weak immune system or chlamydia, taking birth control, and level of income. Having
three or more full term pregnancies places a woman at a higher risk for cancer.
Additionally, a full-term pregnancy at an age younger than 17 years old increases the risk
for cervical cancer to two times more likely when compared to women who waited until
25 years old or order to have children (Blake et al., 2015). Further, women who have a
weak immune system due to HIV or taking immunosuppressive drugs can cause the body
to have a weaker immune system to fight off early cancer (Blake et al., 2015). Research
also shows that patients who have chlamydia infection are at an increased risk for
developing cervical cancer, which they might not be aware of until a pap smear (Hirth et
al., 2015). Gynecologists have also reported that low-income individuals are at more risk
for having cancer due to not being able to early detect some of the risk factors (Wong &
Do, 2012). Teaching patients the risk factors for cervical cancer allows them to change
the things that can be altered and be aware of the factors that cannot be changed to make
sure they get examined regularly for cancer of the cervix.
Further, research has revealed that Black women in the United States are dying
from cervical cancer at a rate 77% higher than previously thought, whereas White women
are dying at a rate 47% higher (Cancer Vaccine Week, 2017). Alabama has the highest
cervical cancer death rate in the United States, and Black women are almost twice as
likely to die of the disease as White women (roughly 5.2 Black women for every 2.7
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White women). This disparity is significant because cervical cancer is preventable and
treatable with adequate gynecological care and early screenings, which generally lead to
a 93% 5-year survival rate. But delayed treatment worsens those chances, and across the
Black Belt, institutionalized racism leaves women neglected by the state’s crumbling
social infrastructure (Chen, 2018). In Alabama, women are dying from the disease at
rates that are higher than in any other state in the United States. Nationwide, Black
women are more likely to die from this disease than women from any other racial or
ethnic group (Chen, 2018).
Cervical cancer can be prevented to a significant extent if screening is done
proactively (Guglielmo et al., 2014). The HPV vaccine and its timely administration also
play a significant role in controlling the incidence of cervical cancer (Petry, 2014). But
there is a link between the attitude toward cervical cancer prevention and the
abnormalities caused by cervical cancer. There was an examination done to verify
whether women with a history of cervical abnormalities expect reactions to cervical
cancer. The measurement was related to the proficiencies of cervical abnormalities that
elaborate politics, outlooks, and actions that are associated with cervical cancer
prevention. The report showed that these women were more positive of observations of
pap testing and HPV vaccination than women who had obtained normal pap testing
results (The Association Between Cervical Abnormalites and Attitudes Toward Cervial
Cancer Prevention, n.d.). Pap tests were perceived as being more effective at reducing the
chance of developing cervical cancer in women if vaccination took place. Intent to
vaccinate their daughters against HPV were highest among women who had cervical
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cancer, women who had hysterectomies, and women who were treated for precancerous
lesions (each p < 0.05). That is, HPV vaccination was favored by the women who had
already suffered cervical cancer abnormalities compared to healthy women.
In terms of prevention, research has also evaluated the efficiency of HPV
vaccines. Two distinct vaccines were evaluated, Gardasil a quadrivalent vaccine
containing virus-like particles of types 6, 11, 16 and 18 and Cervarix, a bivalent vaccine
containing virus-like particles of types 16 and 18 (Schiller et al., 2012). Both vaccines
exhibited excellent safety and immunogenicity profiles. The vaccines also demonstrated
remarkably high and similar efficacy against the vaccine-targeted types for a range of
cervical endpoints from persistent infection to cervical intraepithelial neoplasia grade 3
(CIN3) in women naïve to the corresponding type at the time of vaccination. However,
protection from incident infection or disease from non-vaccine types was restricted, and
the vaccines had no effect on prevalent infection or disease.

Sociocultural Factors and Cervical Cancer
Cervical cancer offers an example of how sociocultural factors such as gender,
ethnicity/race, class, and attitudes toward sexuality converge to shape the risk and
experience of cancer among women.

Race and Ethnicity
Race refers to the categorization of human beings into several groups based on
their physical traits, ethnicity, or genetics such as color of skin (Templeton, 2013).
Analyzed trends in imposing cervical cancer prevalence in relation to 35-year period
reveals that the death rate due to cervical cancer is higher among Black women as
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compared to White women in Alabama though the incidence rate of cervical cancer is
higher in White women (Cervical cancer overview, 2012). Perceived susceptibility to
cervical cancer in Hispanic women seems to be influenced more importantly by the
current or past perception of HPV/STI exposure, and by having a relative with cancer
(Garcés-Palacio & Scarinci, 2012).
A gap was identified about the awareness and knowledge of HPV and HPV
vaccine by race and ethnicity (Blake et al., 2015). Women living in rural areas and of
lower socioeconomic status lead in cervical cancer mortality rate as compared to the
women from urban areas. Further, the death rate due to cervical cancer is higher among
Black and Hispanic women as compared to non-Hispanic White women. The gap existed
not only in awareness and in knowledge about HPV and HPV vaccine, but also in obesity
level and cancer screenings (Jacqueline et al., 2015).
The evaluation of 4,992 women for Pap testing suggested that White women with
a higher household income reported a Pap test with 95% confidence interval as compared
to Black women and other White women with lower household income (Jacqueline et al.,
2015). Research also suggested that insurance coverage also played a crucial role for
cancer screenings for both Black and White women (Madadi et al., 2014). Research has
shown that less than 64.1 percent of low-income populations, specifically African
American and Hispanic women, undergo cervical cancer screenings (Hirth et al., 2015).
This leads to a higher incidence rate of HPV in these specific populations. Data suggested
that 11.5 percent of African American and 14.2 percent of Hispanic women have a
diagnosis of cervical cancer (Hirth et al., 2015). This value is greatly elevated from 8.8
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percent of the general population (Hirth et al., 2015). Some of the suspected factors for
this data include socioeconomic factors, lack of a stable form of healthcare, being
uninsured, not feeling that they are at risk for cervical cancer, and different beliefs
regarding the occurrence and treatment of cancer (Ackerson & Gretebeck, 2007).

Socioeconomic Status
Socioeconomic status is the social standing or class of an individual or group (Lai
et al., 2013). It is often measured as a combination of education, income and occupation.
The awareness about the HPV vaccine and its administration depends upon the education
and income of the individual (Ramirez et al., 2013). Socioeconomic status could be a
barrier in prevention of cervical cancer as the awareness about the adequate measures of
vaccination is not provided in the ethnic group. The most important aspect being
education as it impacts the awareness as well as understanding of the people regarding
the vaccination (D’Orazio et al., 2014).
Women living in rural areas and of lower socioeconomic status lead in cervical
cancer mortality rate as compared to the women from urban areas (Kontos et al., 2012).
Further, the death rate due to cervical cancer is higher among African American and
Hispanic women as compared to non-Hispanic White women (Kontos et al., 2012).
Socioeconomic status influences education level as well as the capacity to seek insurance
coverage. Women with lower socioeconomic status tend to receive lower level of
education and have lower insurance coverage, which in turn, results in lack of cancer
screenings and vaccination (Kontos et al., 2012). The U.S. Census Bureau reports an
increased poverty rate of approximately 25 percent among African American and
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Hispanic individuals (Semega et al., 2017). This far exceeds the 8.6 percent poverty rate
for non-Hispanic White individuals (Semega et al., 2017). For the 41 percent of this
population that is uninsured, the costs of cervical cancer screenings may not be affordable
for them (Semega et al., 2017).
Along with the cost burden, many women in this population have misconceptions
about what the diagnosis of cervical cancer could mean to them (Ramirez et al., 2013).
When asked what they believe about cancer, Hispanic and African American women
responded with saying that “cutting into cancer can make it spread,” that “the treatment
of cancer is worse that the disease,” and that “there is very little a person can do to reduce
their risk of cancer”. Others also stated that if they are not participating in “risk-taking
sexual activities” than there is no need to get screened (Ramirez et al., 2013).
Research indicated that the most basic reason these women chose not to get
screened is because their healthcare provider did not explicitly recommend it to them
(Ackerson & Gretebeck, 2007). This highlights the necessity for the medical personnel to
reach into these communities and provide patient teaching as well and encouragement to
get screened.

Location of Residence
Geography influences the incidence of cervical cancer based on the awareness
and availability of the vaccines in the region (Anhang et al., 2011). It is realized that
women in rural areas exhibit higher mortality rates due to cervical cancer as compared to
the women living in urban areas. This is also because women in rural areas have low
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accessibility of information and knowledge about HPV vaccine and associated cervical
cancer (Anhang et al., 2011).

Sexual Lifestyle
Sexual lifestyle refers to the initiation of sexual activity, number of sexual
partners, and the usage of contraceptives (Finer & Phiblin, 2013). These all influence the
incidence of cervical cancer among women. Initiation of sexual activity at a very early
age increases the risk of HPV infection (Finer & Phiblin, 2013). In addition, unprotected
sex with multiple partners increases the possibility of HPV infection (Finer & Phiblin,
2013). The usage of contraceptive pills for longer duration also increases the possibility
of HPV infection among the females (Ramirez et al., 2013).

Attitude Toward Vaccination
Vaccination is a recognized tool by the medical community for prevention of
particular diseases and for promotion of public health. However, there are individuals
who doubt the benefits and the needs of the vaccination; and consciously decide not to be
vaccinated. This practice of discarding vaccination is also termed as vaccine hesitancy,
which soon is transformed into vaccine refusal (Arbyn et al., 2015)). Hesitancy is not
clear rejection, but the resistance towards vaccination which later combine with lack of
awareness about vaccine benefits results in a decision to not get vaccinated.
The attitude towards vaccination, in general, largely depends upon awareness
about the vaccine benefits. The attitude of ‘hesitancy’ can be changed towards desire of
being vaccinated by adequate communication between the target population and the
providers of the vaccine. The attitude towards vaccine is also impacted with experiences
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of kith and kin (Arbyn et al., 2015). That is, ‘hesitancy’ changes to rejection if vaccine
goes ineffective for anyone in the family or friends.
The acceptance of HPV vaccination for teenage girls also depends upon parental
beliefs about cancer and their trust in health information. It was found that parents were
more likely to accept the vaccine if they perceived a higher risk of getting cancer
themselves and if they had a higher level of trust in health information from medical
authorities. Perceived severity of cancer and fatalistic beliefs about cancer prevention did
not predict vaccine acceptance (Nan et al., 2014). It is vital that parents understand the
benefits of HPV vaccine and accept the same for their daughters well in time in order to
reap the best benefits and enhanced effectiveness of the vaccination against fatal cervical
cancer.
Research suggests, however, that many women do not regularly attend routine
cervical screenings due to both knowledge deficit, as well as fear of results; as many as
38% of women are not seeking cervical screenings due to the latter reasoning (Petry,
2014). This is a big concern to many medical professionals because detection time and
survival rate are very positively correlated. A key role of nursing care is to reduce this
anxiety and fear by providing support and care for each patient as needed (Nan et al.,
2014).
In addition to keeping women informed and at ease, education regarding cervical
cancer and HPV vaccination should be provided to both genders on the importance of
sexual health and particularly, wearing condoms during intercourse (Blake et al., 2015).
HPV infection has been recognized as the main risk factor in the development of cancer.
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Condoms can reduce the rates of HPV infections along with immunizing young females
(Blake et al., 2015).

Cervical Cancer Screening and Treatment
HPV is a highly prevalent, sexually transmitted infection that causes cervical
cancer and contributes towards increasing rates of mortality and morbidity. HPV is
primarily responsible for both high grade and low-grade cervical lesions. HPV types that
are the most common HPV types found in cervical cancer are HPV 16 and 18 and are
responsible for approximately 70% of these cancers (Petry, 2014). On the other hand,
low-risk HPV types, the most common of which are HPV 6 and 11, cause genital warts,
low-grade cervical lesions, and recurrent respiratory papillomatosis, but they do not cause
cervical or other HPV-related cancers (Guglielmo et al., 2014).
The most common way that cervical cancer is found is through a Pap smear
performed by a gynecologist or other healthcare professional (Ashok et al., 2012).
However, there is a possibility of a false positive and false negative result for a Pap smear
test. A false-positive test result indicates that one has a high-risk type of HPV when one
really does not. A false-negative test result means one really does have an HPV infection,
but the test indicates that one does not have any infection (Mayo Clinic, 2018). The
problem of false positives and false negatives can be minimized by avoiding intercourse,
douching, or using any vaginal medicines or spermicidal foams, creams, or jellies for two
days before the test (Reboji et al., 2013).
According to the American Cancer Society (2012), women should begin cervical
cancer screenings when they turn 21 or 3 years after beginning sexual intercourse,
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whichever comes first. This is to detect any changes that occur during the early disease
process. After age 30, women can begin having pap smears every 3 years and they can be
discontinued altogether after the age of 70 if the screenings have been normal for the last
10 years. These guidelines do not seem to be commonly adhered to according to the
CDC’s research that 60% of women diagnosed with cancer have never gotten a pap
smear before or have not had one in 5 years (Arbyn et al., 2015). In the case of abnormal
cells, being found from the Pap smear another test will be done that is called a
colposcopy (Ashok et al., 2012).
A colposcopy involves the use of a colposcopy, which is a magnifying lens device
that is used on the outside of the cervix to see it clearly (Ashok et al., 2012). After
looking through the colposcopy, a biopsy may need to be performed to further examine
abnormal cells in the cervix. A biopsy is a procedure where some tissue from the cervix
is removed for further testing. Biopsies are done to be certain if what looks to be
abnormal is indeed cancer. In addition, a cystoscopy, proctoscopy, and an exam under
anesthesia may be done through the insertion of a lighted tube to view other regions of
the systems to see where the cancer has spread (Ashok et al., 2012).
There are many methods to screening a patient that has been suspected to have
cancer of the cervix. Treatment options can then be determined through the patient and
healthcare physician working together to develop a plan of action to fight the cancer.
Considering pre-cancers and invasive cancers, cryosurgery or laser surgery may be the
treatment chosen. Cryosurgery involves a metal probe that has been cooled with liquid
nitrogen to be placed in vagina and cervix to freeze any of the abnormal cells (Miller,
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2016). Laser surgery is also performed by burning off pre-cancers and removing small
pieces of tissue for biopsy (Ramirez et al., 2013).
Cervical cancer that has reached stage I, can be treated, or found using a
technique called conization (D’Orazio et al., 2014). Conization involves the removal of a
cone shaped piece of tissue from the cervix using a surgical or laser knife (D’Orazio et
al., 2014). This is the procedure of choice for women who still want to have children. In
stage I or II of cervical cancer a hysterectomy may be performed (D’Orazio et al., 2014).
A hysterectomy can be radical or simple, depending on the patient’s specific cancer
(D’Orazio et al., 2014).
A simple hysterectomy includes the removal of the cervix and uterus, while a
radical hysterectomy removes more than the simple hysterectomy (D’Orazio et al., 2014).
It also removes the tissues next to the uterus and the upper part of the vagina next to the
cervix. A radical hysterectomy can include the removal of the ovaries, fallopian tubes,
and lymph nodes as well. A radical hysterectomy is performed more in early-stage II
cancers (D’Orazio et al., 2014). A trachelectomy is a procedure done in the treatment of
cervical cancer but is a method that allows young women to still can give birth. The
uterus is left behind during this surgery and the cervix and upper part of vagina are
removed (D’Orazio et al., 2014).
The risks associated with cancer coming back in this procedure are low but
creates a higher risk for miscarriages than seen in healthy women (Hawkins et al., 2010).
Another treatment option for the more severe cases of cervical cancer involves the use of
radiation or chemotherapy treatments. Radiation therapy is used to kill any cancer cells
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and hopes to shrink any tumors (Ramirez et al., 2013). Radiation is a medical care that
uses high-energy rays like an x-ray to kill the cancer cells. Radiation for cervical cancer
is almost always used alongside with chemotherapy drugs. The chemotherapy drugs that
a doctor prescribes can be taken PO or through an IV, and once in the bloodstream it will
circulate throughout the body (Blake et al., 2015).
Chemotherapy and radiation given together can improve the chances of survival
for the patient (Blake et al., 2015). Medical care can help and may also cure cases of
cervical cancer. However, it is always better to prevent the incidence of cervical cancer
and HPV infection. In the context of cervical cancer, it is important that nurses
consistently educate their patients, particularly by promoting cervical screenings and
encouraging young women to receive HPV vaccinations (Petry, 2014).

HPV Vaccination
HPV infection is most common in young, sexually active populations, and it is
estimated that three fourths of adults will be infected with HPV during their lifetime
(Guglielmo et al., 2014). To control cervical cancer morbidity and mortality rates, it is
paramount that awareness and knowledge about HPV and HPV vaccine should increase.
The increased knowledge of benefits of HPV vaccination should also be able to transform
into willingness to accept the vaccination. The suboptimal acceptance of HPV
vaccination is a worrying cause of concern (Deanna et al., 2012). Earlier, there was no
effective vaccine to reduce the risk of HPV acquisition. Now, two types of HPV
vaccines- quadrivalent and bivalent are available to protect against both high-risk and
low-risk HPV infections (Guglielmo et al., 2014). The vaccination against HPV is
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promising and can reduce HPV-associated morbidity and mortality, if adequately
implemented.
It is important to study cervical cancer diagnosis and to determine the accurate
time when HPV vaccine should be administered among teenage females in order to
enhance the effectiveness of HPV vaccine. Preventive measures are needed and therefore,
HPV vaccine is recommended for females between 13 and 60 years of age (Blake et al.,
2015). The acceptance of HPV vaccine is impacted by several factors. Research indicates
Lai et. al (2013) found that HPV knowledge level was high among US women, but it was
not associated with the willingness to vaccinate their daughters against HPV. Further, it
was also found that the white women displayed higher willingness to accept HPV
vaccination as compared to Black women.
An increased vaccination rate for HPV could result in reduction of HPV infection
and incidence of cervical cancer (Jacqueline et al., 2015). There are two vaccines for
HPV, Gardasil and Cervarix (Ortiz et al., 2012). These vaccines tend to prevent
infections by high-risk HPV types, which cause most cervical cancers (Ortiz et al., 2012).
Gardasil was approved in 2006, and protects against HPV types 6, 11, 16, and 18;
Cervarix was approved in 2009, and protects against HPV types 16 and 18 (Ortiz et al.,
2012). It is important for the HPV vaccination to be administered and all 3 doses are
completed on time for the vaccine to be effective (Ortiz et al., 2012).

Timing of Vaccination, Adolescence vs Post Adolescence
The timing of HPV vaccination is crucial in prevention of the incidence of
cervical cancer. Optimally, the HPV vaccine should be administered before sexual
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initiation (Deanna et al., 2012). The systematic review and meta-analysis to evaluate the
efficacy and safety of HPV vaccines in preventing cervical intraepithelial neoplasia
grades 2 and 3 (CIN2 and CIN3), adenocarcinoma in situ (CIN2+) and cervical cancer
suggested that the vaccines currently available are effective, safe, and capable of
preventing CIN2+ lesions (Rey-Ares et al., 2012). The public health benefits of the
vaccine and cost effectiveness have been validated in multiple studies (White, 2014). For
female patients, the cervical cancer prevention with vaccine administration remains
superior to cervical cancer screening programs employing Papanicolaou smears alone
(Holman et al., 2014).
The CDC recommended schedule is for routine HPV vaccination at ages 11 and
12, with catch-up vaccination up to age 26 for females (Markowitz et al., 2014).
Guidelines recommend that age-eligible women with past exposure to HPV should still
be vaccinated. Little is known about how primary care providers (PCPs) use sexual
history and HPV and Pap tests in their HPV vaccine recommendations (Deanna et al.,
2012). A healthcare provider’s recommendation is the strongest known predictor of
initiation and completion the 3-dose HPV vaccine series (Dorell et al., 2012, Kessels et
al., 2012).

Availability and Accessibility to Vaccination
This is a major concern as the availability and accessibility of HPV vaccination is
important to control the incidence of cervical cancer. This depends upon the geographical
location and socioeconomic status of the people (D’Orazio et al., 2014). It is important to
create high level awareness about the benefits of the vaccination and to make it available
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and accessible for every woman. The rate of contraction has increased despite vaccine
availability (Jacqueline et al., 2015).
Research reveals that a huge gap exists about awareness and knowledge about
HPV vaccine by sex, education, income, race/ethnicity, geographic area, and other
important sociodemographic characteristics (Blake et al., 2015). This gap in awareness
also leads to the difference in mortality and morbidity rates caused due to HPV infection.
Women living in rural areas and of lower socioeconomic status lead in cervical cancer
mortality rate as compared to the women from urban areas (Ramirez et al., 2013).
Further, the death rate due to cervical cancer is higher among African American and
Hispanic women as compared to non-Hispanic White women (Ramirez et al., 2013).

Previous Studies and Methodology Used
Jassim et al. (2018) explored the knowledge, attitudes, and practices of women
attending primary care health centers for cervical cancer screening among women
visiting primary health care centers in Bahrain. In this cross-sectional quantitative study,
300 women were taken as a sample. A validated tool comprised of 45 items to collect
data through face-to-face interviews between December 2015 and February 2016. The
participants demonstrated a wide range of knowledge and attitudes towards cervical
cancer screening. However, the majority demonstrated positive attitudes towards the
HPV vaccine (Jassim et al., 2018).
Assoumou et al. (2015) conducted a quantitative study to assess the awareness
and knowledge about cervical cancer, Pap smear testing and its use and HPV among
women living in Libreville, Gabon. A total of 452 women aged 16 years and older were
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recruited from different town locations. Logistic regression analysis was used to identify
the effect of demographic characteristics on the level of knowledge about cervical cancer,
Pap smear testing and HPV. Odds ratio and 95% confidence intervals were used to
identify the strength of association. This study demonstrates a very low level of
knowledge about cervical cancer, Pap smear testing and HPV in a sample of Gabonese
women. There is a critical need for Gabonese women to be informed about cervical
cancer and the Pap smear test to improve the use of this preventive method (Assoumou et
al., 2015).
Daley et al. (2013) initiated a quantitative study to examine Pap smear knowledge
among three high-risk populations at different points in time. The study employed
frequencies and logistic regression to examine associations between demographic factors
and accurate knowledge of Pap smear testing within three separate HPV psychosocial
studies. The three studies were conducted - (1) HPV-positive women (prevaccine
population in 2005-2006, n = 154, mean age 23.5), (2) college women (postvaccine
population in 2008, n = 276, mean age 18.9), and (3) minority college women
(postvaccine population in 2011, n = 711, mean age 23.3) (Daley et al., 2013).
Knowledge about the purpose of the Pap smear remains low. Findings underscore the
significant need for clear and consistent messages among high-risk women regarding the
prevention of cervical cancer and other reproductive health conditions (Daley et al.,
2013).
Al-Shaikh et al. (2014) assessed the level of knowledge regarding cervical cancer
and the acceptance of the human papilloma virus (HPV) vaccine among Saudi female
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students in health colleges through a study. Approximately 1400 students from Health
Colleges at Princess Nora Bint Abdul Rahman University, Riyadh, Saudi Arabia were
conveniently selected as a sample for cross-sectional quantitative study. A selfadministrated questionnaire was distributed to all participants. Data collected included
socio-demographic data, knowledge of cervical cancer risk factors and clinical
presentation, Pap smear, and HPV vaccine acceptance. Vaccine acceptance is influenced
by its price; approximately 80% of students thought that an affordable vaccine price
should not exceed 300 Saudi Riyals. Perceived barriers to the vaccine were fear of
injections and vaccine side effects (Al-Shaikh et al., 2014). A lack of knowledge and
misinformation exists regarding cervical cancer, Pap smear, and HPV as a major risk
factor for cancer of the cervix.

Summary and Conclusion
Research indicates that there is a difference in the awareness and knowledge
about HPV vaccine by sex, education, income, race/ethnicity, geographic area, and other
sociodemographic characteristics. It is important to target populations that are still
unaware about the benefits of HPV vaccine. Women of lower socioeconomic status and
of races such as African American, Hispanic, and Black. need adequate knowledge about
HPV vaccine and associated cervical cancer morbidity and mortality. Women living in
rural areas and of lower socioeconomic status lead the cervical cancer mortality rate as
compared to the women from urban areas. Further, the death rate due to cervical cancer is
higher among African American and Hispanic women as compared to non-Hispanic
White women. The race, level of household income, education, as well as insurance
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coverage impacts the vaccination and cancer screenings among women. HPV vaccine is
effective if it is administered at an early age before a woman is infected with the virus.
However, if the vaccine is administered after the woman is already infected, then it would
not result in positive effect. In addition, there are several types of HPV vaccines and they
need to be administered taking other parameters of the women in consideration. Providers
may also be recommending the vaccine to women who may receive little benefit from the
vaccine. Provider and system-level efforts to improve guideline-consistent practices are
needed. Chapter 3 will provide description of the research methods that will be used to
conduct this study and include data collection, data analysis, and ethical considerations.
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Chapter 3: Research Method
The purpose of this study was to determine whether there was statistically
significant difference in the diagnosis of cervical cancer in women who received the HPV
vaccine compared to women who did not receive the vaccine, considering demographic
factors (race, ethnicity, county of residence, level of education, household income),
personal risk factors (sexual orientation, cigarette use, diet, and type of contraception
use), and factors affecting access to healthcare (type of healthcare coverage, delay in
receiving medical care). An additional purpose of this study was to determine whether
there was a significant difference in the diagnosis of cervical cancer in women who
received the HPV vaccine based on the number of HPV shots received and the presence
or absence of sexual activity. Chapter 3 includes information about the research design,
methodology, data collection, data analysis, threats to validity, and ethical considerations
for this study.

Research Design and Rationale
A quasi-experimental (non-equivalent group design) for this quantitative study
was selected because it allowed me to assign numerical values to the variables and
manipulate and analyze a larger dataset. Additionally, it helped me to draw cause–effect
inferences. These designs often use intact groups that are similar to an extent so that they
are fairly compared, though the groups may not be comparable, and it is unlikely that the
two groups are similar if they were assigned through a random lottery (The Use and
Interpretation of Quasi-Experimental Studies in Medical Informatics, n.d.)Because it is
often likely that the groups are not equivalent (as in this study), there are two groups that
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are similar in several ways but are non-equivalent, which allows fair comparison between
the two groups. There were no anticipated time or resource constraints in the conduct of
this study.
For this study, the independent variables were race, ethnicity, county of residence,
level of education, household income, type of healthcare coverage, delay in receiving
medical care, sexual orientation, cigarette use, diet, type of contraception use, vaccine
administration, number of HPV shots received, and the presence of sexual activity. The
dependent variable of the study was the diagnosis of HPV. The research questions and
hypotheses for this study are:
Research Question 1: Is there a statistically significant difference in the diagnosis
of cervical cancer in women who received and did not receive the HPV vaccine
considering demographic factors (race, ethnicity, level of education, household income)
and factors affecting access to healthcare (type of healthcare coverage, delay in receiving
medical care)?

H01: There is no statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering
demographic factors (race, ethnicity, level of education, household income) and factors
affecting access to healthcare (type of healthcare coverage, delay in receiving medical
care).

H11: There is a statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering
demographic factors (race, ethnicity, level of education, household income) and factors
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affecting access to healthcare (type of healthcare coverage, delay in receiving medical
care).
Research Question 2: Is there a statistically significant difference in the diagnosis
of cervical cancer in women who received and did not receive the HPV vaccine
considering personal risk factors (sexual orientation, cigarette use, diet, and type of
contraception use)?

H02: There is no statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering personal
risk factors (sexual orientation, cigarette use, diet, and type of contraception use).

H12: There is a statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering personal
risk factors (sexual orientation, cigarette use, diet, and type of contraception use).
Research Question 3: Is there a statistically significant difference in the diagnosis
of cervical cancer in women who received the HPV vaccine based on the number of HPV
shots received, and the presence of sexual activity?

H02: There is no statistically significant difference in the diagnosis of cervical
cancer in women who received the HPV vaccine based on the number of HPV shots
received, and the presence of sexual activity.

H12: There is a statistically significant difference in the diagnosis of cervical
cancer in Remove women who received the HPV vaccine based on the number of HPV
shots received, and the presence of sexual activity.
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Methodology
Population
In 2015, in the United States there were 2,123 females were diagnosed with
cervical cancer, which is 8.5 per 100,000 (Alabama Statewide Cancer Registry, n.d.). I
used data from secondary data analysis from the 2017 BRFSS for females between the
ages of 18 and 60 who had been diagnosed with cervical cancer.

Sampling and Sampling Procedures
Based on the research questions and hypotheses, stratified sampling strategy was
the most appropriate choice for this research study. Specifically, proportional random
stratified sampling was done by race, which uniformly divided the population into
different homogenous groups (Frankfort-Nachmias & Nachmias, 2008). Stratified
sampling strategy ensured that all the groups are uniformly represented. The sample was
females between 18 to 60 years of age with or without a cervical cancer diagnosis in the
United States.
The application used to compute sample size was G*Power version 3.1.9.2.
Sample size was calculated using effect size, alpha level, and power level. An alpha level
of 0.05 and a power of 80% was used. Effect size (moderate) provided a higher chance to
detect a difference between the groups. These parameters were used as these are the most
feasible levels to avoid Type 1 and Type II errors. Based on these parameters, the sample
size was 568 females based on the G* power analysis.
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Data Collection
Secondary data from the 2017 BRFSS was used to select the population that met
my inclusion criteria. This is a publicly available dataset, which I accessed after obtaining
institutional review board (IRB) approval from Walden University (approval #10-04-190470159). For this secondary data analysis, data were de-identified. Data deidentification prevents a connection between the information and an individual’s identity
(Clinical and Intervention Setting, n.d.)The data are stored in a password protected laptop
and will be destroyed after 5 years. The federal regulations allow for IRBs to exempt
research using archival data when certain conditions exist, including removing a
participant’s identity from the data (Institutional Review Board, 2018, para. 1).

Operationalization of Variables
Table 1 provides specific information for each of the study variables.
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Table 1

Study Variables
Variable name
Diagnosis of Cervical
Cancer

Variable type
DV, Nominal

Survey
question #
6.7, 13.3

HPV Vaccination

IV, Nominal

19.1

Number of HPV Shots

IV, Nominal

19.2

Race

IV, Nominal

8.4

Ethnicity

IV, Nominal

8.3

Level of Education

IV, Nominal

8.7

Household Income

IV, Nominal

8.17

Data codes
1 = Yes
2 = No
7 = Don’t know / Not sure
1 = Yes
2 = No
3 = Doctor refused when asked
7 = Don’t know / Not sure
9 = Refused
_ _ Number of shots
0 3 = All shots
77 = Don’t know / Not sure
10 = White
20 = Black or African American
30 =American Indian or Alaska Native
40 = Asian
41 = Asian Indian
42 = Chinese
43 = Filipino
44 = Japanese
45 = Korean
46 = Vietnamese
47 = Other Asian
50 = Pacific Islander
51 = Native Hawaiian
52 = Guamanian or Chamorro
53 = Samoan
1 = Mexican, Mexican American, Chicano/a
2 = Puerto Rican
3 = Cuban
4 = Another Hispanic, Latino/a, or Spanish origin
1 = Never attended school or only attended
kindergarten
2 = Grades 1 through 8 (Elementary)
3 = Grades 9 through 11 (Some high school)
4 = Grade 12 or GED (High school graduate)
5 = College 1 year to 3 years (Some college or
technical school)
6 = College 4 years or more (College graduate)
04 = Less than $25,000 ($20,000 to less than $25,000)
03 = Less than $20,000 ($15,000 to less than $20,000)
02 = Less than $15,000 ($10,000 to less than $15,000)
01 = Less than $10,000
05 = Less than $35,000 ($25,000 to less than $35,000)
06 = Less than $50,000 ($35,000 to less than $50,000)
07 = Less than $75,000 ($50,000 to less than $75,000)
08 = $75,000 or more

(table continues)
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Variable name
Type of healthcare coverage

Variable type
IV, Nominal

Delay in Medical Care

IV, Nominal

Cigarette Use

IV, Nominal

Type of Contraception

IV, Nominal

Sexual Activity

IV, Nominal

Sexual Orientation

IV, Nominal

Survey question # Data codes
10.2
01 = A plan purchased through an employer or
union (includes plans purchased through another
person’s employer)
02 = A plan that you or another family member
buys on your own
03 = Medicare
04 = Medicaid or other state program
05 TRICARE (formerly CHAMPUS), VA, or
Military
06 = Alaska Native, Indian Health Service,
Tribal Health Services,
07 = Some other source, or
08 = None (no coverage)
10.3
1 = You couldn’t get through on the telephone.
2 = You couldn’t get an appointment soon
enough.
3 = Once you got there, you had to wait too long
to see the doctor.
4 = The (clinic/doctor’s) office wasn’t open
when you got there.
5 = You didn’t have transportation.
9.2
1 = Every day
2 = Some days
3 = Not at all
7 = Don’t know / Not sure
9 = Refused
17.1
01 = Female sterilization (e.g., Tubal ligation,
Essure, Adiana)
02 = Male sterilization (vasectomy)
03 = Contraceptive implant (e.g., Implanon)
04 = Levonorgestrel (LNG) or hormonal IUD
(e.g., Mirena)
05 = Copper-bearing IUD (e.g., ParaGard)
06 = IUD, type unknown
07 = Shots (e.g., Depo-Provera)
08 = Birth control pills, any kind
09 = Contraceptive patch (e.g., Ortho Evra)
10 = Contraceptive ring (e.g., NuvaRing)
11 Male condoms
12 = Diaphragm, cervical cap, sponge
13 Female condoms
14 = Not having sex at certain times (rhythm or
natural family planning)
15 = Withdrawal (or pulling out)
16 = Foam, jelly, film, or cream
17 = Emergency contraception (morning after
pill)
18 = Other method
17.1
1 = Yes
2,3 = No
27.1
1 = Straight
2 = Lesbian or gay
3 = Bisexual

(table continues)
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Variable name

Variable type

Diet

IV, Nominal

Survey question # Data codes
12.1, 12.3, 12.4, Not including juices, how often did you eat
12.612.1
fruit? (times per day, week, or month)
1_ _ Days
2_ _ Weeks
3_ _ Months
888 = Never
777 = Don’t Know
999 = Refused
12.3
How often did you eat a green leafy or lettuce
salad, with or without other vegetables?
1_ _ Days
2_ _ Weeks
3_ _ Months
888 = Never
777 = Don’t Know
999 = Refused
12.6
Not including lettuce salads and potatoes, how
often did you eat other vegetables?
1_ _ Days
2_ _ Weeks
3_ _ Months
888 Never
777 = Don’t Know
999 = Refused
12.4
How often did you eat any kind of fried
potatoes, including french fries, home fries, or
hash browns?
1_ _ Days
2_ _ Weeks
3_ _ Months
888 = Never
777 = Don’t Know

Note. IV = independent Variable, DV = dependent variable
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Data Analysis
The data was collected for all the independent variables-race, ethnicity, level of
education, household income, type of healthcare coverage, delay in receiving medical
care, sexual orientation, cigarette use, diet, type of contraception use, number of HPV
shots received, and the presence of sexual activity. Descriptive data analysis was
performed to determine frequencies and percentages for the independent variables.
Binomial logistic regression analysis was used to analyze data from this study.
Regression analysis is used primarily to analyze variability and provide prediction. It
predicts the value of a dependent (response) variable based on the value of at least one
independent (explanatory) variable (Laerd Statistics, 2018). It will be helpful to analyze
the effect of the independent variables on the dependent variable (Daniel, 2010).
There are assumptions of binomial logistic regression that need to be met in order
to generate a valid result. To run binomial logistic regression, it is assumed that the
dependent variable is measured on a dichotomous scale; there is more than one
independent variable (either continuous or categorical), observations are independent of
each other, independent variables should not be in terms with multicollinearity, and linear
relationship between independent variables and log odds (Laerd Statistics, 2018).
A correlation matrix is used to determine multicollinear relationships between
independent variables. If there is multicollinearity between any two predictor variables,
then the correlation coefficient between these two variables will be near to unity.
Considering the situation, when two variables strongly correlate with each other or if they
are measuring the same thing, then the problem of multicollinearity exists. Then, the
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remedy is to drop one of the predictor variables to lessen the multicollinearity. Otherwise,
the confidence interval of coefficients becomes wide, statistics tends to be exceedingly
small, and it becomes difficult to reject the null hypothesis. If it is impossible to drop the
concerned variable, then alternative methods of estimation like ridge regression or
principal component regression would be utilized. Multicollinearity was assessed using
variance inflation factors (VIFs).
Ridge regression gives an alternative estimator (k) that has a smaller total mean
square error value. The value of k can be estimated by looking at the ridge trace plot from
one approach. Ridge trace plot is a plot of parameter estimates vs k where k usually lies
in the interval of [0,1]. The principal component regression approach combats
multicollinearity by using less than the full set of principal components in the model. To
obtain the principal components estimators, assume that the regressors are arranged in
order of decreasing eigenvalues, λ1 ≥ λ2……. ≥ λp >0. In principal components
regression, the principal components corresponding to near zero eigenvalues are removed
from the analysis and least squares applied to the remaining components. However, all
VIF values were below 10, indicating that multicollinearity was not a concern (see Table
4, Table 8, and Table 11). I had planned to use ridge regression, but this was not adopted
as the VIF values were below 10.
SPSS version 21 was used to analyze data for this study. Records with missing
data were not included in the analysis. Data from this study were analyzed to answer the
following research questions:
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Research Question 1: Is there a statistically significant difference in the diagnosis
of cervical cancer in women who received and did not receive the HPV vaccine
considering demographic factors (race, ethnicity, level of education, household income)
and factors affecting access to healthcare (type of healthcare coverage, delay in receiving
medical care)?

H01: There is no statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering
demographic factors (race, ethnicity, level of education, household income) and factors
affecting access to healthcare (type of healthcare coverage, delay in receiving medical
care).

H11: There is a statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering
demographic factors (race, ethnicity, level of education, household income) and factors
affecting access to healthcare (type of healthcare coverage, delay in receiving medical
care).
Binomial logistic regression analysis was conducted to answer research question
one considering the diagnosis of cervical cancer as the dependent dichotomous variable
and race, ethnicity, level of education, household income, type of healthcare coverage,
and delay in receiving medical care as independent variables. The null hypothesis was
rejected if a p value < 0.05 was observed.
Research Question 2: Is there a statistically significant difference in the diagnosis
of cervical cancer in women who received and did not receive the HPV vaccine
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considering personal risk factors (sexual orientation, cigarette use, diet, and type of
contraception use)?

H02: There is no statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering personal
risk factors (sexual orientation, cigarette use, diet, and type of contraception use).

H12: There is a statistically significant difference in the diagnosis of cervical
cancer in women who received and did not receive the HPV vaccine considering personal
risk factors (sexual orientation, cigarette use, diet, and type of contraception use).
Research Question 3: Is there a statistically significant difference in the diagnosis
of cervical cancer in women who received the HPV vaccine based on the number of HPV
shots received and the presence of sexual activity?

H03: There is no statistically significant difference in the diagnosis of cervical
cancer in women who received the HPV vaccine based on the number of HPV shots
received and the presence of sexual activity.

H13: There is a statistically significant difference in the diagnosis of cervical
cancer in women who received the HPV vaccine based on the number of HPV shots
received, and the presence of sexual activity.
Binomial logistic regression analysis was conducted to answer research question
two considering the diagnosis of cervical cancer as the dependent dichotomous variable
and the number of HPV shots received, and the presence of sexual activity as
independent variables. The null hypothesis was rejected if a p value < 0.05 was observed.
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Threats to Validity
There are three types of validity associated with measurement. They are construct
validity, empirical validity, and content validity (Creswell, 2009). A design is valid when
it meets the validity with evidence. The validity of the research design is concerned with
the intervention of factors that stimulate dependent variables. The validity of the research
design can be easily established if the research design is generalizable and can be easily
applied to real world situations. The factors outside of the experiment tend to assess
internal and external validity of the research design.
The study was associated with internal validity threats. The external validity
threats were not of concern as the study was carried out using secondary data. However,
study would not be generalized for external environment with larger population. The
internal validity threats arose from the previous experiences of the participants that may
impact the behavior of the participants and influence the result. The threats to statistical
conclusion validity were addressed by using a p value of < .05 to determine statistical
significance.
Reliability of a research design refers to the ability of the study to be trustworthy
over a period. The reliability of this study could be ensured by using adequate scholarly
resources as literature review. The reliability of the research design could also be ensured
by assessing the gaps in the literature and by identifying the reason for this gap with the
prevailing trends. The research study could address the gaps and should also consider the
current scenario and expected future trends.
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Ethical Procedures
Before conducting my research, approval from the Institutional Review Board
(IRB) at Walden University was obtained (IRB# 10-04-19-0470159). Approval through
written agreements that would provide access to data was obtained. Consent was not
required as secondary data was used. Data was de-identified and anonymous. The data
collected is stored in a password protected laptop. The data is accessible only by myself
and will destroy the data by deleting from my laptop after 5 years from the end of my
research study.

Summary
This research study used quantitative research methodology and consisted of
secondary data analysis from the 2017 BRFSS. I analyzed data about cervical cancer
diagnosis, HPV vaccination, demographics, and personal risk factors for cervical cancer
in females, ages 18-60. Chapter 4 will provide the results of the data analysis.
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Chapter 4: Results
The purpose of this study was to determine whether there was a statistically
significant difference in cervical cancer diagnosis between women who received the HPV
vaccine and those who did not, with consideration for demographic factors (race,
ethnicity, level of education, household income), personal risk factors (sexual orientation,
cigarette use, diet, and type of contraception use), and factors affecting access to
healthcare (type of healthcare coverage, delay in receiving medical care). I also examined
whether there was a difference in cervical cancer diagnosis in women who received the
HPV vaccine based on the number of HPV shots received and the presence of sexual
activity. Chapter 4 includes information about data collection and results of statistical
analysis.

Data Collection
For this study, secondary data from the 2017 BRFSS were analyzed. Because
there were no data available for cervical cancer diagnosis or HPV vaccination for the
cases in Alabama, I analyzed data from all females in the 2017 dataset. The independent
variables were race, ethnicity, level of education, household income, type of healthcare
coverage, delay in receiving medical care, sexual orientation, cigarette use, diet, type of
contraception use, number of HPV shots received, and the presence of sexual activity.
The dependent variable of the study was the diagnosis of cervical cancer.
There was a total of 251,007 female cases in the dataset. Table 2 displays
descriptive statistics for the demographic variables in this sample. Most women in the
sample identified as White (n = 203,237, 81.0%) and not Hispanic (n = 228,267, 90.9%).
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The largest proportion of women had earned a college degree or higher (n = 92,050,
36.7%). The largest proportion of women had an income level of $75,000 per year or
more (n = 59,486, 23.7%).
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Table 2

Frequencies and Percentages for Demographic Variables
Variable
Race
White
Black or African American
American Indian or Alaskan Native
Asian
Hawaiian or Pacific Islander
Other
No preferred race
Do not know
Missing

Frequency

Percent

203,237
23,731
5,763
5,230
1,662
5,013
792
2,206
3,373

81.0
9.5
2.3
2.1
0.7
2.0
0.3
0.9
1.3

Ethnicity
Hispanic
Not Hispanic
Missing

20,534
228,267
2,206

8.2
90.9
0.9

Education level
Never attended
Elementary
Some high school
High school
Some college
College graduate
Missing

322
5,663
11,973
67,114
72,965
92,050
920

0.1
2.3
4.8
26.7
29.1
36.7
0.4

Income level
Less than $10,000
Less than $15,000
Less than $20,000
Less than $25,000
Less than $35,000
Less than $50,000
Less than $75,000
$75,000 or more
Do not know
Missing

11,647
12,256
17,182
20,447
22,909
28,603
31,201
59,486
21,909
25,367

4.6
4.9
6.8
8.1
9.1
11.4
12.4
23.7
8.7
10.1
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Results
Research Question 1
Research Question 1: Is there a statistically significant difference in the diagnosis
of cervical cancer in women who received and did not receive the HPV vaccine
considering demographic factors (race, ethnicity, level of education, household income)
and factors affecting access to healthcare (type of healthcare coverage, delay in receiving
medical care)? Table 3 displays descriptive statistics for the variables included in
Research Question 1. Less than 1% of women in the sample had a cervical cancer
diagnosis and had received the HPV vaccine. Additionally, approximately 90% of the
sample had no data available for type of healthcare coverage or delay in medical care.
After list wise exclusion of cases missing data for these variables, no cases with cervical
cancer diagnoses remained. Therefore, to conduct the analysis for Research Question 1,
the variables for type of healthcare coverage and delay in receiving medical care were
omitted from the analysis.
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Table 3

Frequencies and Percentages for Cervical Cancer Diagnosis, HPV Vaccination,
Healthcare Coverage, and Delay in Medical Care
Variable
Cervical cancer diagnosis
No
Yes

Frequency

Percent

250,754
253

99.9
0.1

Received HPV vaccine
No
Yes

249,905
1,102

99.6
0.4

Primary health insurance coverage
Employer plan
Own plan
Medicare
Medicaid or state program
TRICARE VA or Military
Indian Health Service
Other
None
Do not know
Missing

8,704
2,555
8,350
2,134
414
29
825
24
231
227,741

3.5
1
3.3
0.9
0.2
0
0.3
0
0.1
90.7

Delayed getting medical care
Could not get through on phone
Could not get appointment
Doctor wait was too long
Doctor office was not open
No transportation
Other
Do not know
No delay
Missing

328
1,753
784
189
1,201
1,273
138
19,847
225,494

0.1
0.7
0.3
0.1
0.5
0.5
0.1
7.9
89.8
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Additionally, a binary logistic regression was conducted to address this question,
with the dependent variable being cervical cancer diagnosis. Before interpreting the
results of the regression, multicollinearity was assessed using VIFs. All VIF values were
below 10, indicating that multicollinearity was not a concern (see Table 4).
Table 4

Variance Inflation Factors for Research Question 1
Variable
HPV vaccine
Race
Ethnicity
Education
Income

VIF
1.00
1.25
1.22
1.29
1.27

2

The result for the overall binary logistic regression model was significant, χ (22)
= 142.21, p < .001, suggesting that collectively the independent variables significantly
predicted cervical cancer diagnosis. The Cox and Snell R2 and Nagelkerke R2 were .001
and .039, respectively, indicating the predictors accounted for 0.10 – 3.90% of the
variance in cervical cancer diagnosis. Receiving the HPV vaccine was a significant
predictor of cervical cancer diagnosis, B = 1.17, OR = 3.23, p = .044, indicating that,
after controlling for the demographic variables, women who received the HPV vaccine,
were 3.23 times more likely to have a diagnosis of cervical cancer. Because there was a
significant difference in cervical cancer diagnosis between women who received and did
not receive the HPV vaccine, the null hypothesis was rejected. Table 5 presents the
regression coefficients for the binary logistic regressle 5
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Binary Logistic Regression Predicting Cervical Cancer Diagnosis (Research Question 1)
Variable

B

SE

(Intercept)
HPV vaccine
Race: White
Race: Black or African American
Race: American Indian or Alaskan Native
Race: Asian
Race: Hawaiian or Pacific Islander
Race: Other
Race: No preferred race
Ethnicity: Hispanic
Education: Never attended
Education: Elementary
Education: Some high school
Education: High school
Education: Some college
Income: Less than $10,000
Income: Less than $15,000
Income: Less than $20,000
Income: Less than $25,000
Income: Less than $35,000
Income: Less than $50,000
Income: Less than $75,000
Income: $75,000 or more

-6.62
1.17
-0.84
-1.99
-0.00
-2.41
-13.64
-0.97
-0.64
-1.93
-11.70
0.84
-0.07
0.42
0.51
1.24
1.14
0.85
0.86
0.43
0.52
0.11
-0.34

0.80
0.58
0.75
0.82
0.79
1.25
264.29
1.00
1.25
0.50
609.50
0.40
0.36
0.19
0.19
0.33
0.32
0.32
0.31
0.33
0.31
0.33
0.33

2

χ
68.12
4.04
1.23
5.96
0.00
3.69
0.00
0.94
0.26
14.95
0.00
4.29
0.04
4.75
7.50
14.31
12.37
6.90
7.71
1.72
2.80
0.11
1.04

p

OR

< .001
.044
.266
.015
1.000
.055
.959
.332
.611
< .001
.985
.038
.837
.029
.006
< .001
< .001
.009
.005
.190
.094
.744
.308

3.23
0.43
0.14
1.00
0.09
0.00
0.38
0.53
0.15
0.00
2.31
0.93
1.53
1.66
3.47
3.13
2.33
2.37
1.54
1.69
1.11
0.71
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The Black category of race was a significant predictor of cervical cancer
diagnosis, B = -1.99, OR = 0.14, p = .015, indicating that Black or African American
individuals were 0.14 times as likely to have a diagnosis of cervical cancer. Ethnicity was
a significant predictor of cervical cancer diagnosis, B = -1.93, OR = 0.15, p < .001,
indicating that Hispanic individuals were 0.15 times as likely to have a diagnosis of
cervical cancer. The elementary, high school, and some college categories of education
were significant predictors of cervical cancer diagnosis (p-values < .05), indicating that
individuals with elementary, high school, or some college levels of education were more
likely to have a diagnosis of cervical cancer. The income categories less than $25,000
were significant predictors of cervical cancer diagnosis (p-values < .05), indicating that
individuals with income levels less than $25,000 were more likely to have a diagnosis of
cervical cancer.

Research Question 2
Is there a statistically significant difference in the diagnosis of cervical cancer in
women who received and did not receive the HPV vaccine considering personal risk
factors (sexual orientation, cigarette use, diet, and type of contraception use)? The
independent variables for Research Question 2 included HPV vaccination, sexual
orientation, cigarette use, diet (calculated daily servings of fruit, greens, other vegetables,
and fried potatoes), and type of contraception use. The dependent variable was diagnosis
of cervical cancer. Tables 6 and 7 display descriptive statistics for the variables included
in Research Question 2.
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Table 6

Frequencies and Percentages for Sexual Orientation, Cigarette Use, and Type of
Contraception
Variable
Sexual orientation
Do not know
Straight
Lesbian or gay
Bisexual
Other
Missing
Cigarette use
Every day
Never smoked
Not at all
Some days
Missing
Type of contraception
Do not know
None or NA
Female sterilization
Male sterilization
Implant
LNG or IUD
Copper bearing IUD
Other IUD
Shots
Pills
Patch
Ring
Male condoms
Diaphragm
Female condoms
Rhythm or natural
Withdrawal
Foam jelly film or cream
Emergency contraception
Other
Missing

Frequency

Percent

1,251
106,595
1,330
2,303
559
138,969

0.50
42.47
0.53
0.92
0.22
55.36

23,046
147,974
60,448
9,567
9,972

9.18
58.95
24.08
3.81
3.97

94
23,945
1,953
1,870
816
795
466
1,839
446
5,017
101
191
5,148
47
121
117
427
29
37

0.04
9.54
0.78
0.74
0.33
0.32
0.19
0.73
0.18
2.00
0.04
0.08
2.05
0.02
0.05
0.05
0.17
0.01
0.01

638

0.25

206,910

82.43
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Table 7

Means and Standard Deviations for Diet Variables (Calculated Daily Servings)
Variable
Fruit
Greens
Other vegetables
Fried potatoes

M
1.25
0.65
1.10
0.17

SD
1.78
1.35
2.12
0.39

A binary logistic regression was conducted to address this question, with the
dependent variable being cervical cancer diagnosis. Before interpreting the results of the
regression, multicollinearity was assessed using VIFs. All VIF values were below 10,
indicating that multicollinearity was not a problem (see Table 8).
Table 8

Variance Inflation Factors for Research Question 2
Variable
HPV vaccine
Sexual orientation
Cigarette use
Fruit
Greens
Other vegetables
Fried potatoes
Contraception

VIF
1.03
1.03
1.11
3.90
1.02
3.85
1.03
1.06

The result for the overall binary logistic regression model was significant, χ2(31)
= 52.42, p = .009, suggesting that collectively the independent variables significantly
predicted cervical cancer diagnosis. The Cox and Snell R2 and Nagelkerke R2 were .002
and .138, respectively, indicating the model accounted for 0.20 – 13.80% of the variance
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in cervical cancer diagnosis. Receiving the HPV vaccine was a significant predictor of
cervical cancer diagnosis, B = 2.00, OR = 7.40, p = .002, indicating that, after controlling
for the personal risk factors, women who received the HPV vaccine, were 7.40 times
more likely to have a diagnosis of cervical cancer. Because there was a significant
difference in cervical cancer diagnosis between women who received and did not receive
the HPV vaccine, the null hypothesis was rejected. Table 9 presents the regression
coefficients for the binary logistic regression.
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Table 9

Binary Logistic Regression Predicting Cervical Cancer Diagnosis (Research Question 2)
Variable

B

SE

(Intercept)
HPV vaccine

-35.28
2.00

Orientation: Straight

14.68

2

p

OR

6770.79
0.63

χ
0.00
9.98

.996
.002

7.40

2809.52

0.00

.996

2.38 × 10
0.32

6

6

Orientation: Lesbian or gay

-1.13

3544.68

0.00

1.000

Orientation: Bisexual

15.82

2809.52

0.00

.996

Orientation: Other
Cigarettes: Never smoked
Cigarettes: Not at all
Cigarettes: Some days
Fruit
Greens
Other vegetables
Fried potatoes

-0.61
-2.54
-1.33
-0.63
0.11
-0.27
-0.04
-0.98

4765.54
0.55
0.59
0.66
0.10
0.40
0.11
0.95

0.00
21.32
5.12
0.93
1.22
0.46
0.13
1.05

1.000
< .001
.024
.334
.269
.500
.721
.305

7.44 × 10
0.54
0.08
0.26
0.53
1.12
0.77
0.96
0.38

Contraception: None or NA

15.23

6160.37

0.00

.998

4.11 × 10

6

Contraception: Female sterilization

16.29

6160.37

0.00

.998

1.19 × 10

7

Contraception: Male sterilization

15.47

6160.37

0.00

.998

6

Contraception: Implant
Contraception: LNG or IUD
Contraception: Copper bearing IUD
Contraception: Other IUD
Contraception: Shots

-0.41
-0.39
-0.25
-0.29
-0.68

6453.94
6542.14
6724.47
6319.41
6734.43

0.00
0.00
0.00
0.00
0.00

1.000
1.000
1.000
1.000
1.000

5.22 × 10
0.66
0.67
0.78
0.75
0.51

Contraception: Pills

14.84

6160.37

0.00

.998

6

Contraception: Patch
Contraception: Ring

-0.31
-0.27

8251.77
7370.15

0.00
0.00

1.000
1.000

2.79 × 10
0.74
0.76

Contraception: Male condoms

14.77

6160.37

0.00

.998

6

Contraception: Diaphragm
Contraception: Female condoms
Contraception: Rhythm or natural
Contraception: Withdrawal
Contraception: Foam jelly film or
cream
Contraception: Emergency
contraception
Contraception: Other

-0.07
-0.40
-0.15
-0.59

13024.04
8493.15
8452.18
6742.15

0.00
0.00
0.00
0.00

1.000
1.000
1.000
1.000

2.60 × 10
0.93
0.67
0.86
0.56

-1.69

12147.21

0.00

1.000

0.18

0.04

11213.87

0.00

1.000

1.05

-0.27

6556.26

0.00

1.000

0.76
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The “never smoked” and “not at all” categories of cigarette use were significant
predictors of cervical cancer diagnosis (p-values < .05), indicating that individuals who
smoked never or not at all were less likely to have a diagnosis of cervical cancer.

Research Question 3
Is there a statistically difference in the diagnosis of cervical cancer in women who
received the HPV vaccine based on the number of HPV shots received, and the presence
of sexual activity? The independent variables for Research Question 3 included the
number of HPV shots received, and the presence of sexual activity. The dependent
variable was diagnosis of cervical cancer. Table 10 displays descriptive statistics for the
variables included in Research Question 3.
Table 10

Frequencies and Percentages for HPV Shots and Sexual Activity
Variable
Number of HPV shots
Do not know
1
2
All shots
Missing
Sexually active
Yes
No
Missing

Frequency

Percent

159
234
175
529
249,910

0.06
0.09
0.07
0.21
99.56

40,781
4,167
206,059

16.25
1.66
82.09

A binary logistic regression was conducted to address this question, with the
dependent variable being cervical cancer diagnosis. Only women who had received the
HPV vaccine were included in this analysis. Before interpreting the results of the
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regression, multicollinearity was assessed using VIFs. All VIF values were below 10
(1.00 for race, HPV shots, and sexual activity), indicating that multicollinearity was not a
problem.

The result for the overall binary logistic regression model was not significant,
χ2(11) = 5.85, p = .883, suggesting that collectively the independent variables did not
significantly predict cervical cancer diagnosis. The Cox and Snell R2 and Nagelkerke R2
were .009 and .155, respectively, indicating the predictors accounted for 0.90 – 15.50%
of the variance in cervical cancer diagnosis. Because no predictors were significant, the
null hypothesis was not rejected. Table 11 presents the regression coefficients for the
binary logistic regression.
Table 11

Binary Logistic Regression Predicting Cervical Cancer Diagnosis (Research Question 3)
2

Variable

B

SE

(Intercept)
Race: White
Race: Black or African American
Race: American Indian or
Alaskan Native
Race: Asian
Race: Hawaiian or Pacific
Islander
Race: Other
Race: No preferred race
Shots: 1
Shots: 2
Shots: All
Sexual activity: No

-36.43
14.93
15.33

10387.27
9438.04
9438.04

χ
0.00
0.00
0.00

-0.26

15285.13

0.00 1.000

0.77

-0.97

12558.00

0.00 1.000

0.38

15.22

25162.93

0.00 1.000

4071007.96

-0.63
-1.29
-0.01
0.04
16.52
1.22

19209.57
41286.21
5295.46
5730.43
4338.06
1.24

0.00
0.00
0.00
0.00
0.00
0.97

0.53
0.28
0.99
1.04
14876606.39
3.39

p

OR

.997
.999
.999

0.00
3047555.36
4527623.96

1.000
1.000
1.000
1.000
.997
.325
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Summary
Three binary logistics regression analyses were conducted to answer the research
questions. The results for Research Question 1 showed that there was a significant
difference in the diagnosis of cervical cancer in women who received and did not receive
the HPV vaccine after controlling for demographic factors; the null hypothesis was
rejected. The results for Research Question 2 showed that there was a significant
difference in the diagnosis of cervical cancer in women who received and did not receive
the HPV vaccine after controlling for personal risk factors; the null hypothesis was
rejected. The results for Research Question 3 showed that there were no differences in the
diagnosis of cervical cancer in women who received the HPV vaccine based on the
number of HPV shots received, or the presence of sexual activity; the null hypothesis was
not rejected. Chapter 5 will contain a discussion of results, limitations, and
recommendations for future research.
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Chapter 5: Discussion, Conclusions, and Recommendations
The purpose of this study was to determine if there was a statistically significant
difference in the diagnosis of cervical cancer in women who received the HPV vaccine as
compared to women who did not receive the vaccine, with the consideration of
demographic factors (race, ethnicity, level of education, household income), personal risk
factors (sexual orientation, cigarette use, diet, and type of contraception use), and factors
affecting access to healthcare (type of healthcare coverage, delay in receiving medical
care). In addition, I also examined if there was a difference in the diagnosis of cervical
cancer in women who received the HPV vaccine based on the number of HPV vaccines
received and the presence of sexual activity.
Cervical cancer has been the third most diagnosed cancer and the fourth leading
cause of cancer death in females worldwide (Miller, 2016). In 2017, 12,820 women in the
United States were diagnosed with cervical cancer and 4,210 deaths from the disease
occurred (ASCO, 2018). However, a decreased amount of research has been identified
about personal risk factors for cervical cancer, factors affecting access to health care, and
HPV vaccination in women based on demographic factors. It is also important to
determine the accurate time when HPV vaccine should be administered among teenage
females to enhance the effectiveness of HPV vaccine. In this study, I intended to address
the gap in the literature regarding the underlying causes of higher death rates in certain
racial groups of females due to cervical cancer. I examined whether there was a
difference in cancer diagnosis between those who did and did not receive the HPV
vaccine based on demographic factors (race, ethnicity, level of education, household
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income), personal risk factors (sexual orientation, cigarette use, diet, and type of
contraception use), and factors affecting access to healthcare (type of healthcare
coverage, delay in receiving medical care). I also examined number of HPV vaccines and
sexual activity. For this quantitative study, I conducted secondary data analysis from the
2017 BRFSS. Data were selected from females between the ages of 18 to 60, who have
been diagnosed with cervical cancer, as well as females who tested negative for cervical
cancer.
The results of this study showed that there was a significant difference in the
diagnosis of cervical cancer in women who received and did not receive the HPV vaccine
after controlling for demographic factors and a significant difference in the diagnosis of
cervical cancer in women who received and did not receive the HPV vaccine after
controlling for personal risk factors. The findings also showed that there was no
significant difference in the diagnosis of cervical cancer in women who received the HPV
vaccine based on the number of HPV shots received or the presence of sexual activity. In
this chapter, I will provide an interpretation of the findings, limitations of the study,
recommendations, and implications.

Interpretation of the Findings
The significant findings from this study suggest that patients should inquire about
their health care coverage to receive the HPV vaccine. Approximately 90% of the sample
had no data available for the type of healthcare coverage or delay in medical care.
Considering list wise exclusion of cases missing data for these variables, no cases with
cervical cancer diagnoses remained.
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Additionally, the significant findings from this study suggest that Black women
should see their oncologist for reliable cervical cancer diagnosis. The Black category of
race was a significant predictor of cervical cancer diagnosis, B = -1.99, OR = 0.14, p =
.015, indicating that Black or African American individuals were 0.14 times as likely to
have a diagnosis of cervical cancer. Ethnicity was also a significant predictor of cervical
cancer diagnosis, B = -1.93, OR = 0.15, p < .001, indicating that Hispanic individuals
were 0.15 times as likely to have a diagnosis of cervical cancer. Regarding other
demographic factors, the elementary, high school, and some college categories of
education were significant predictors of cervical cancer diagnosis (p < .05), indicating
that individuals with these levels of education were more likely to have a diagnosis of
cervical cancer. The income categories less than $25,000 were significant predictors of
cervical cancer diagnosis (p < .05), indicating that individuals with income levels less
than $25,000 were more likely to have a diagnosis of cervical cancer. If income is less
than $25,000 annually, this would not be sufficient to cover medical procedures.
Additionally, the results revealed that the HPV vaccine should be provided
because there was a significant difference in cervical cancer diagnosis between women
who received and did not receive the HPV vaccine. Receiving the HPV vaccine was a
significant predictor of cervical cancer diagnosis, B = 2.00, OR = 7.40, p = .002,
indicating that, after controlling for the personal risk factors, women who received the
HPV vaccine were 7.40 times more likely to have a diagnosis of cervical cancer.
The study addressed the gap in the literature by identifying possible demographic
and personal risk factors for cervical cancer leading to higher death rates in certain racial
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groups of females (Tabatbhai et al., 2014). Additionally, the social cognitive theory
helped explain the pattern of change in human behavior regarding administration of HPV
vaccine during adolescence. The dependent constructs of the theory are learning and
change in behavior, which can be measured in terms of incidence of cervical cancer;
independent constructs are personal factors (initiation of sexual activity, ethnicity, and
lifestyle), behavior (socioeconomic status), and environment (geographic location). The
dependent constructs of the theory depend on and responds to independent constructs of
the theory. Thus, this theory helped to explain the incidence of cervical cancer as an
interaction of personal factors (initiation of sexual activity), behavior (lifestyle), and
environment (geographic location, socioeconomic status; Bandura, 1989).

Limitations of the Study
The major limitation of the study was that the data collected through a
questionnaire may be biased and the patients may not have provided correct information.
As I used secondary data for my analysis, I was not able to address these limitations. The
progress in the HPV vaccine over the period when it was administered to the selected
sample and the time of the research study is another major limitation. The gap between
the time of the collected data and the timing of the research study has witnessed
technological changes that might affect the validity of the research. To address this
limitation, I used the most recent available data relevant to my research study.

Recommendations
As no research has been found about HPV vaccination in women living in
Alabama, a recommendation for future research would be to conduct a quantitative study
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on women from Alabama to provide confirmation of consistency of the findings in
reference to the difference in the diagnosis of cervical cancer in women who received the
HPV vaccine compared to women who did not receive the vaccine. Demographic factors
(race ethnicity, county of residence, level of education, household income), personal risk
factors (sexual orientation, cigarette use, diet, and type of contraception use), and factors
affecting access to healthcare (type of healthcare coverage, delay in receiving medical
care) should be considered in this recommendation.
Additionally, implementing a qualitative study with a phenomenological approach
could help determine how women should schedule cervical examinations with their
physicians. These objectives can proceed to address and close the gap in literature about
HPV vaccination and cervical cancer because of lack of research that has been stipulated
in reference to personal risk factors, factors affecting access to health care, and HPV
vaccination in women based on demographic factors.

Implications of Findings
The findings of the study were generally aligned with the literature of the topic of
the study. These results indicate a reflection on the demographic and personal risk factors
for cervical cancer in a certain group of females. The results also provide insight on a
perspective of education, income, health care coverage, receiving medical care. These
results may inform the structure of patient care, which could provide individuals with
guidance throughout the process of treatment if cervical cancer is detected. The potential
positive social change that could result from this study is increased rate and timely
administration of HPV vaccination for women, which may lead to decreased death rates
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from cervical cancer. The results of this study can also raise awareness in education for
families, organizations, and the society. These objectives can encourage the public to take
advantage of their health by regularly visiting their healthcare providers annually to
ensure that they are in proper health. Women should consult with their physician for
reliable testing to confirm a diagnosis of HPV and vaccines. If there is a situation when
health care cost is unaffordable, patients can seek nonprofit organizations for their health
care necessaries. Enough health care coverage should be provided in the process of
receiving treatment because this plays a major role in the quality of health care treatment
received.

Summary and Conclusion
This research study used a quantitative research methodology and consisted of
secondary data analysis from the 2017 BRFSS for females ages 18 to 60 diagnosed with
cervical cancer as well as those who tested negative for cervical cancer. Females may or
may not have received the HPV vaccine. Results of this study revealed that there was a
statistically significant difference in the diagnosis of cervical cancer in women who
received and did not receive the HPV vaccine after controlling for demographic factors
and a statistically significant difference in the diagnosis of cervical cancer in women who
received and did not receive the HPV vaccine after controlling for personal risk factors.
Based on the findings of this study, health care organizations may wish to raise
awareness of cervical cancer among certain racial groups. Furthermore, because of the
increased rates of cervical cancer in certain racial groups, there should be a more
proactive approach to cervical cancer prevention and detection.
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